申请人:NIPPON SHINYAKU COMPANY, LIMITED
公开号:EP0159040A2
公开(公告)日:1985-10-23
1,4-Dihydropyridine-3-carboxylates having the general formula
and the pharmacologically acceptable salts thereof are found to exhibit marked coronary vasodilating, hypotensive and other vasodilating actions with very little toxicity, so that they can be widely applied as remedies for circulatory diseases.
研究发现,具有通式的 1,4-二氢吡啶-3-羧酸盐及其药理学上可接受的盐类具有明显的冠状动脉血管扩张、降血压和其他血管扩张作用,且毒性极低,因此可广泛用作治疗循环系统疾病的药物。